Sigyn Therapeutics, Inc.
SIGY
$2.76
-$0.99-26.40%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.71% | 8.77% | 19.43% | -4.30% | -1.45% |
| Total Depreciation and Amortization | -35.38% | -27.27% | -35.23% | -23.08% | -46.72% |
| Total Amortization of Deferred Charges | -42.01% | -36.10% | -58.04% | -27.77% | -30.20% |
| Total Other Non-Cash Items | 1,308.40% | 390.71% | 348.22% | 400.87% | 158.17% |
| Change in Net Operating Assets | -32.03% | -13.91% | 48.72% | 317.89% | 876.77% |
| Cash from Operations | 1.04% | 11.83% | 36.93% | 58.40% | 51.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -6.87% | 27.90% | -29.03% | -50.29% | -49.57% |
| Total Debt Repaid | -55.56% | -375.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | -9.85% | 18.86% | -37.04% | -53.52% | -50.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.00% | 93.13% | -88.24% | 174.25% | 84.05% |